Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.42 USD -7.56% Market Closed
Updated: Jun 1, 2024

Phathom Pharmaceuticals Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Phathom Pharmaceuticals Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Current Portion of Long-Term Debt
$7.1m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Current Portion of Long-Term Debt
$2.3B
CAGR 3-Years
-10%
CAGR 5-Years
13%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Current Portion of Long-Term Debt
$2.9B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
26%
Pfizer Inc
NYSE:PFE
Current Portion of Long-Term Debt
$1B
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-20%
Merck & Co Inc
NYSE:MRK
Current Portion of Long-Term Debt
$3.1B
CAGR 3-Years
-25%
CAGR 5-Years
-1%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Current Portion of Long-Term Debt
$1.7B
CAGR 3-Years
591%
CAGR 5-Years
-7%
CAGR 10-Years
68%

See Also

What is Phathom Pharmaceuticals Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
7.1m USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Current Portion of Long-Term Debt amounts to 7.1m USD.

What is Phathom Pharmaceuticals Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
-1%

The average annual Current Portion of Long-Term Debt growth rates for Phathom Pharmaceuticals Inc have been -1% over the past three years .